IGC
Price
$0.31
Change
+$0.02 (+6.90%)
Updated
Apr 24 closing price
Capitalization
25.01M
54 days until earnings call
LRMR
Price
$2.37
Change
+$0.11 (+4.87%)
Updated
Apr 24 closing price
Capitalization
151.75M
13 days until earnings call
Ad is loading...

IGC vs LRMR

Header iconIGC vs LRMR Comparison
Open Charts IGC vs LRMRBanner chart's image
IGC Pharma
Price$0.31
Change+$0.02 (+6.90%)
Volume$941.43K
Capitalization25.01M
Larimar Therapeutics
Price$2.37
Change+$0.11 (+4.87%)
Volume$676.46K
Capitalization151.75M
IGC vs LRMR Comparison Chart
Loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGC vs. LRMR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a StrongBuy and LRMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IGC: $0.31 vs. LRMR: $2.37)
Brand notoriety: IGC and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 281% vs. LRMR: 78%
Market capitalization -- IGC: $25.01M vs. LRMR: $151.75M
IGC [@Biotechnology] is valued at $25.01M. LRMR’s [@Biotechnology] market capitalization is $151.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than IGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 5 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • IGC’s TA Score: 5 bullish, 5 bearish.
  • LRMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IGC and LRMR are a good buy in the short-term.

Price Growth

IGC (@Biotechnology) experienced а +10.61% price change this week, while LRMR (@Biotechnology) price change was +24.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

IGC is expected to report earnings on Aug 08, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($152M) has a higher market cap than IGC($25M). IGC YTD gains are higher at: -6.607 vs. LRMR (-38.760). IGC has higher annual earnings (EBITDA): -7.58M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. IGC (470K). IGC has less debt than LRMR: IGC (270K) vs LRMR (5.36M). IGC has higher revenues than LRMR: IGC (1.24M) vs LRMR (0).
IGCLRMRIGC / LRMR
Capitalization25M152M16%
EBITDA-7.58M-73.44M10%
Gain YTD-6.607-38.76017%
P/E RatioN/AN/A-
Revenue1.24M0-
Total Cash470K204M0%
Total Debt270K5.36M5%
FUNDAMENTALS RATINGS
IGC vs LRMR: Fundamental Ratings
IGC
LRMR
OUTLOOK RATING
1..100
2227
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
7890
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is in the same range as IGC (51) in the Biotechnology industry. This means that LRMR’s stock grew similarly to IGC’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as IGC (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to IGC’s over the last 12 months.

IGC's SMR Rating (96) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that IGC’s stock grew similarly to LRMR’s over the last 12 months.

IGC's Price Growth Rating (78) in the Biotechnology industry is in the same range as LRMR (90) in the null industry. This means that IGC’s stock grew similarly to LRMR’s over the last 12 months.

IGC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that IGC’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCLRMR
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLOAX7.720.12
+1.58%
Cohen & Steers Future of Energy A
FPHAX23.40N/A
N/A
Fidelity Select Pharmaceuticals Port
DTCYX17.01N/A
N/A
BNY Mellon Sust US Equity Y
LYRZX12.50N/A
N/A
Lyrical International Value Equity C
GICCX13.13N/A
N/A
Goldman Sachs Intl Sm Cp Insghts C

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
+6.73%
TECX - IGC
39%
Loosely correlated
+14.53%
ANVS - IGC
30%
Poorly correlated
+8.61%
AMLX - IGC
30%
Poorly correlated
+3.56%
LRMR - IGC
29%
Poorly correlated
+4.87%
VTGN - IGC
27%
Poorly correlated
+7.34%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+4.87%
SVRA - LRMR
46%
Loosely correlated
+0.62%
ERAS - LRMR
46%
Loosely correlated
-1.41%
ACLX - LRMR
45%
Loosely correlated
+0.53%
PRME - LRMR
45%
Loosely correlated
-1.69%
IMNM - LRMR
44%
Loosely correlated
+0.24%
More